---
**Patient Name:** Timmy Kirlin  
**MRN:** 009827153  
**DOB:** 06/30/1924 (Age: 99)  
**Sex:** Male  
**Admit Date:** 2024-05-20  
**Attending:** Dr. Simon O’Leary  
**Service:** Cardiac ICU  
**Location:** 5E-ICU, Bed 12  

---

### **Admission H&P (05/20/2024 14:15)**

**Chief Complaint:**  
Acute shortness of breath, altered mental status.

**History of Present Illness:**  
99-year-old male with a PMHx notable for seizure disorder (h/o single seizure, epilepsy), obesity, prediabetes, anemia, osteoarthritis of hand, prostate neoplasm (h/o carcinoma in situ, on leuprolide and docetaxel), Alzheimer’s dementia, recurrent pharyngitis/sinusitis, prior stroke, h/o clavicle fracture, and recent pneumonia. Presented from SNF with 2 days of progressive dyspnea, confusion, productive cough, and decreased oral intake. On arrival, the patient was hypoxic (SpO2 86% RA), tachypneic, febrile to 38.3°C, and hypotensive (BP 85/52 mmHg). Initial ECG showed new-onset atrial fibrillation with RVR. CXR: Pulmonary edema vs. multifocal pneumonia. Labs: mild troponin elevation, AKI, hyperkalemia. Given IV fluids, started on broad-spectrum antibiotics, but rapidly decompensated—requiring intubation and pressors. TTE: Severe LV dysfunction (EF 18%), global hypokinesis, moderate MR. Cardiology consulted, Impella CP placed for cardiogenic shock.

**Past Medical History:**  
- Seizure disorder, h/o single seizure  
- Epilepsy  
- Obesity (BMI >30)  
- Prediabetes  
- Anemia  
- Osteoarthritis (hand)  
- h/o Prostate neoplasm (carcinoma in situ, on docetaxel/leuprolide)  
- Alzheimer’s disease  
- Recurrent viral/bacterial pharyngitis, sinusitis  
- Stroke (remote, L-sided weakness, improved)  
- h/o Clavicle fracture  
- Pneumonia (recent, treated)  

**Past Surgical History:**  
- None relevant

**Allergies:**  
- NKDA

**Home Medications:**  
- Naproxen 220mg PO prn  
- Docetaxel 20mg/mL IV q3wks  
- Leuprolide 30mg/mL q3mo  
- Galantamine 4mg PO BID  
- Memantine 2mg/mL PO BID  
- Penicillin VK 500mg PO BID (recent)  
- Clopidogrel 75mg PO daily  
- Alteplase 100mg IV (prior stroke, not given this admission)  
- Acetaminophen/oxycodone 325/5mg PO q6h prn  

**Social History:**  
- Lives in SNF  
- Widower, no children  
- Ambulates with walker pre-admission  
- No tobacco, EtOH, drugs

**Family History:**  
- Noncontributory

**Review of Systems:**  
- Unable to obtain (intubated, sedated)

**Physical Exam (on admission):**  
- Gen: Cachectic elderly male, intubated  
- Vitals: T 38.2°C, HR 121, BP 82/46, RR 28 (vent), SpO2 94% (FiO2 60%)  
- HEENT: Oropharynx clear, no exudate  
- CV: Irregularly irregular, soft S1/S2, 2/6 holosystolic murmur, cool extremities, delayed cap refill  
- Lungs: Bibasilar crackles, decreased breath sounds RLL  
- Abd: Soft, NT, ND, mild suprapubic tenderness  
- Neuro: Nonverbal, opens eyes to pain, localizes, no posturing  
- Skin: No rashes, mild sacral erythema  

---

### **Problem-Based Assessment & Plan (05/21/2024)**

#### **1. Cardiogenic Shock due to Acute Decompensated Heart Failure**
- Etiology: Likely multifactorial—ischemic vs. tachyarrhythmia-induced. Severe LV dysfunction (EF 18%) on TTE.
- Placed Impella CP for hemodynamic support on 5/20.
- Norepinephrine, vasopressin for MAP >65.
- Diuresis with IV furosemide—net negative 2.4L in 36h.
- Serial TTEs, daily lactate, cardiac markers.
- Plan: Wean pressors as tolerated; titrate Impella flows; daily echo; consider weaning Impella if hemodynamics stable >24h.

#### **2. Acute Hypoxic Respiratory Failure, Intubated**
- Etiology: Multifocal pneumonia vs. pulmonary edema (CXR, exam, leukocytosis, hypoxemia).
- Mechanical ventilation, lung protective settings.
- Empiric abx: vancomycin, cefepime, azithromycin (pending cultures).
- Daily CXR, respiratory cultures sent.
- Extubation readiness eval daily.

#### **3. New-Onset Atrial Fibrillation with RVR**
- Rate control: IV diltiazem (now HR 80-110).
- Anticoagulation: On clopidogrel (h/o stroke), heparin gtt held for ongoing GI bleed risk.
- Monitor for conversion, TTE for LA thrombus.

#### **4. Alzheimer’s Disease, Advanced**
- Severe cognitive impairment, MMSE ~5 at baseline.
- Continue galantamine, memantine as able.
- Family updated, DPOA involved.

#### **5. Prostate Neoplasm (Carcinoma in Situ)**
- Onc in house. Continue leuprolide, docetaxel held during critical illness.
- PSA pending.

#### **6. Anemia (baseline), AKI**
- Hgb fell from 11.2 → 8.3 over 48h; suspect dilutional v. GI loss (NGT clear).
- Renal: Creatinine peaked 2.1 → 1.3 with improved perfusion.
- Monitor H/H, transfuse prn.

#### **7. Obesity, Prediabetes**
- BG 110–145, sliding scale insulin.
- D/c metformin (AKI), monitor for improvement.

#### **8. Osteoarthritis, Clavicle Fracture (remote)**
- Pain controlled; continue acetaminophen/oxycodone prn.
- PT/OT on hold.

#### **9. Recent Infections (Pneumonia, Pharyngitis, Sinusitis)**
- Continue abx, monitor for superinfection.

#### **10. DVT Prophylaxis, Skin Integrity**
- SCDs, heparin held (GI bleed risk).
- Turn q2h, barrier creams.

#### **11. Goals of Care/Code Status**
- Full code per family, but poor functional baseline.
- Family conference scheduled.

---

### **Progress Note (05/23/2024 09:17)**

**Subjective:**  
Patient remains intubated, sedated. No new complaints.

**Objective:**  
- Vitals: T 37.8°C, HR 96, BP 101/56, MAP 68, SpO2 98% (FiO2 45%)
- I/Os: Net negative 1.1L past 24h
- Exam: Chest clear, heart irregular, mild LE edema, nonfocal neuro exam
- Impella: Flows 3.2L/min, minimal hemolysis
- CXR: Improved congestion, persistent RLL infiltrate
- Labs: See below

---

### **LABS**

| Date       | WBC (10^3/uL) | Hgb (g/dL) | Plt (10^3/uL) | Na (mmol/L) | K (mmol/L) | Cl (mmol/L) | CO2 (mmol/L) | BUN (mg/dL) | Cr (mg/dL) | Glu (mg/dL) | Ca (mg/dL) | Troponin (ng/mL) | BNP (pg/mL) | AST (U/L) | ALT (U/L) |
|------------|---------------|------------|---------------|-------------|------------|-------------|--------------|-------------|------------|-------------|------------|-------------------|-------------|-----------|-----------|
| 05/20/24   | 15.8          | 11.2       | 172           | 146         | 5.7        | 110         | 22           | 38          | 2.1        | 143         | 8.7        | 0.19              | 2860        | 55        | 38        |
| 05/21/24   | 13.1          | 9.6        | 155           | 143         | 4.8        | 109         | 24           | 23          | 1.5        | 129         | 9.2        | 0.06              | 1950        | 42        | 33        |
| 05/22/24   | 12.4          | 8.3        | 139           | 140         | 4.2        | 108         | 27           | 19          | 1.3        | 121         | 9.5        | 0.04              | 1380        | 33        | 29        |
| 05/23/24   | 10.9          | 8.7        | 144           | 141         | 3.9        | 106         | 28           | 17          | 1.2        | 117         |            | 0.03              | 1120        | 28        |           |
| 05/24/24   |               | 9.1        | 132           | 142         | 4.1        | 107         | 26           | 18          | 1.2        |             | 9.6        |                   | 890         |           | 23        |

**Other notable labs:**  
- Lactate: 3.2 → 1.9 mmol/L (improved)  
- Procalcitonin: 0.38 → 0.22 ng/mL  
- INR: 1.3–1.4  
- PSA pending  
- Blood cultures x2: no growth  
- Sputum: pending

---

### **Imaging**

- **CXR (05/20):** Diffuse interstitial edema, RLL infiltrate  
- **CXR (05/22):** Improved edema, RLL persistent  
- **TTE (05/20):** Severe global LV dysfunction (EF 18%), mod MR, mild RV dilation  
- **TTE (05/23):** EF 23%, Impella well-seated, no thrombus

---

### **Procedures**

- **Impella CP placement (05/20/24):** Left femoral artery, US-guided, no complications
- **Intubation (05/20/24):** 7.5 ETT, fixed at 22cm
- **Central line (R IJ), A-line (L radial)**

---

### **Medications (Active Orders)**

- Vancomycin IV 1g q12h
- Cefepime IV 2g q8h
- Azithromycin IV 500mg q24h
- Diltiazem drip (per protocol)
- Furosemide IV 40mg q8h
- Norepinephrine, vasopressin (PRN)
- Clopidogrel 75mg PO daily
- Galantamine, memantine (hold if unable PO)
- Acetaminophen/oxycodone 325/5mg PO/NGT q6h PRN

---

### **Consults**
- Cardiology: Impella management
- Infectious Disease: Abx guidance
- Palliative Care: GOC discussion
- Oncology: Prostate neoplasm

---

### **Discharge Planning**
- Prognosis guarded given age, comorbidities, advanced dementia
- Awaiting family meeting for GOC
- Plan for Impella wean if stable
- Anticipate prolonged ICU stay

---

### **Summary/Attending Note (05/25/2024)**

**Timmy Kirlin** is a 99-year-old male with advanced Alzheimer’s, severe LV dysfunction, and multiple comorbidities admitted in cardiogenic shock. Required Impella CP support, intubation, and pressors. Now improving but remains critically ill. Prognosis poor, goals of care discussion ongoing.

---

**Signed:**  
Simon O’Leary, MD  
Cardiac ICU  
05/25/2024 09:25

---
